Jun 28, 2026 08:24AM
Mar 9, 2026 10:53AM
Feb 20, 2026 10:57AM
Feb 20, 2026 10:57AM
Jan 14, 2026 08:49AM
Dec 2, 2025 08:01AM
Dec 2, 2025 08:00AM Aurigene Oncology Limited Announces Encouraging Initial Data From 1st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies
Oct 22, 2025 12:00PM
Aug 25, 2025 08:00AM
May 9, 2025 02:53PM
Mar 13, 2025 10:40AM
Aug 20, 2024 02:53PM
Aug 20, 2024 02:42PM
Jul 27, 2024 09:51AM Dr. Reddy’s Q1FY25 Financial Results
May 7, 2024 10:31AM
May 3, 2024 08:00AM
Mar 22, 2024 07:00AM
Jan 31, 2024 09:44AM
Dec 6, 2023 07:01AM
Dec 6, 2023 07:00AM
Jul 12, 2023 10:25AM Dr. Reddy’s Proposed Rituximab Biosimilar Application Accepted for Review by USFDA, EMA and MHRA
May 5, 2023 07:18AM
Apr 21, 2023 07:15AM
Apr 5, 2023 06:55AM
Jan 27, 2023 07:03AM
Jul 27, 2022 03:26AM
Jul 22, 2022 06:17AM
Jul 8, 2022 11:51AM Dr. Reddys Labs (RDY) Announces Launch of Fesoterodine Fumarate Extended-Release Tablets in the U.S. Market
Jul 8, 2022 11:48AM
Jun 24, 2022 07:31AM
Jun 24, 2022 07:30AM
Jun 24, 2022 07:30AM
Jun 14, 2022 02:51AM
May 27, 2022 10:15AM
May 24, 2022 01:41PM Dr. Reddys Labs (RDY) and Senores Launch Ketorolac Tromethamine Tablets USP, 10 mg in the US
May 24, 2022 01:40PM
Apr 20, 2022 12:41PM
Apr 5, 2022 06:52AM
Feb 9, 2022 09:19AM
Feb 9, 2022 09:17AM
Dec 10, 2021 01:46PM
Dec 9, 2021 11:47PM Dr. Reddy's Laboratories Announces the Launch of Venlafaxine ER Tablets in the U.S. Market
Dec 9, 2021 03:18AM
Dec 9, 2021 12:50AM
Dec 8, 2021 09:00PM
Oct 29, 2021 08:59AM
Oct 29, 2021 08:59AM
Oct 19, 2021 05:30AM
Oct 19, 2021 12:14AM Dr. Reddy's Laboratories Announces Approval for Lenalidomide Capsules from the U.S. Food and Drug Administration (USFDA)
Oct 15, 2021 01:40PM

325,552 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All